Could a more extensive surgery keep kidney cancer from coming back?

NCT ID NCT07321197

Recruiting now Disease control Sponsor: Tianjin Medical University Second Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two surgical approaches for high-risk kidney cancer: a standard limited lymph node removal versus a more thorough 'template' dissection. Researchers want to see if the more extensive surgery helps prevent cancer from returning and improves survival. About 220 participants will be randomly assigned to one of the two procedures and followed for up to 10 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Template Lymph Node Dissection (surgical procedure)
What this could lead to: If successful, this could establish a new standard surgical approach to reduce the risk of kidney cancer returning and improve long-term survival.
What could go wrong: This is a relatively early-stage trial with 220 participants, so results may not apply to all patients. The more extensive surgery may carry higher risks of complications like bleeding or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA (KIDNEY CANCER) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

kidney cancer renal cell carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RENAL CELL CARCINOMA (KIDNEY CANCER)

Contacts and locations

Locations

Tianjin Medical University Second Hospital
RECRUITING

Tianjin, Tianjin Municipality, 300211, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.